Shareholders' equity · 2011–2025
Adma Biologics shareholders' equity
$477M+36.8% · FY2025
Adma Biologics (ADMA) reported $477M in shareholders' equity for fiscal 2025, +36.8% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $477M | +36.8% | Open → |
| FY20242024-12-31 | $349M | +158.1% | Open → |
| FY20232023-12-31 | $135M | −11.0% | Open → |
| FY20222022-12-31 | $152M | +7.7% | Open → |
| FY20212021-12-31 | $141M | +60.0% | Open → |
| FY20202020-12-31 | $88.2M | +236.9% | Open → |
| FY20192019-12-31 | $26.2M | +32.5% | Open → |
| FY20182018-12-31 | $19.8M | −51.0% | Open → |
| FY20172017-12-31 | $40.3M | +$44.8M | Open → |
| FY20162016-12-31 | −$4.5M | −$5.3M | Open → |
| FY20152015-12-31 | $820,974 | −86.3% | Open → |
| FY20142014-12-31 | $6.0M | −72.1% | Open → |
| FY20132013-12-31 | $21.6M | +128.9% | Open → |
| FY20122012-12-31 | $9.4M | +2,342.5% | Open → |
| FY20112011-12-31 | $385,816 | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +66.3%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Adma Biologics shareholders' equity |url=https://companiesranked.com/en/company/adma-biologics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Adma Biologics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/adma-biologics/shareholders-equityBibTeX
@misc{companiesranked-en-company-adma-biologics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Adma Biologics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/adma-biologics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001140361-26-031445 · August 5, 2026
{{cite web |title=Adma Biologics shareholders' equity — 10-Q (0001140361-26-031445) |url=https://www.sec.gov/Archives/edgar/data/1368514/000114036126031445/ef20075111_10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.